logo

Biomerica Inc (BMRA)



Trade BMRA now with
  Date
  Headline
1/16/2018 9:32:01 AM Biomerica Q2 Sales Up 12.7%
1/10/2018 8:21:28 AM Chinese FDA Oks Biomerica Colorectal Screening Test To Help Identify Early Warning Signs Of Colorectal Cancer
1/8/2018 8:28:46 AM Biomerica Signs Agreements To Initiate Clinical Study For IBS Diagnostic Guided Therapy
1/4/2018 12:24:48 PM B. Riley FBR Starts BIOMERICA INC (BMRA) At Buy With $7.50 Price Target
11/7/2017 8:20:40 AM Biomerica Extends Exclusive License Agreement With Celtis Pharm Of South Korea
10/17/2017 8:22:22 AM Biomerica Q1 Net Loss $207,059, Net Sales $1.44 Mln
9/12/2017 8:19:53 AM Biomerica Begins Clinical Studies For New Gastroenterology H. Pylori Test
8/30/2017 8:20:34 AM Biomerica 2017 Net Loss $908,561 Vs. Net Loss Of $1.50 Mln Prior Year
8/16/2017 8:21:29 AM Biomerica Announces Point Of Care Product Distribution Deal With Multinational Pharmaceutical Company
4/17/2017 8:26:43 AM Biomerica Q3 Net Loss $304,141 Vs Net Loss $135,002 Last Year
1/18/2017 8:21:05 AM Biomerica Q2 Loss Per Share $0.02 Vs Loss $0.01 Last Year
10/18/2016 7:58:01 AM Biomerica Q1 Net Loss $55K Vs Loss $72K Last Year
10/4/2016 7:57:41 AM Biomerica Highlights Recent Scientific Reports Indicating Increased Prevalence Of IBS
8/30/2016 9:30:07 AM Biomerica FY Net Sales $5.14 Mln Vs. $4.96 Mln Prior Year
8/24/2016 8:20:57 AM Biomerica To Begin Trading On Nasdaq On August 26
7/11/2016 7:48:16 AM FDA Determines That Biomerica's Proposed InFoods IBS Clinical Investigation Is A Nonsignificant Risk Device Study